Biovance Solutions, a UK based Company, leading provider of pharmacovigilance, regulatory, and pre-clinical research services, has signed a Memorandum of Understanding (MoU) with MIET (Meerut Institute of Engineering & Technology) to foster collaboration in the areas of Pharmacovigilance (PV), Regulatory Affairs, and Pre-Clinical Trial Services.

In the 1970s, India was facing a silent epidemic of cataract blindness. Millions of elderly people were losing their eyesight, not because treatment was unavailable, but because it was unaffordable. Cataract surgery required replacing the cloudy natural lens with a clear artificial intraocular lens (IOL). At that time, these lenses were imported and cost nearly 100 US dollars each, far beyond the reach of poor patients.

At the center of the solution was a remarkable man, Dr. Govindappa Venkataswamy, lovingly known as Dr. V.